• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study calculates costs associated with smoking by patients with cancer

Bioengineer by Bioengineer
April 5, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Credit: MUSC Hollings Cancer Center, Emma Vought

A study released today in JAMA Network Open reported that smoking after a cancer diagnosis is associated with substantial additional costs of cancer treatment.

Hollings Cancer Center researcher Graham Warren, M.D., Ph.D., says the study establishes a model to estimate the economic burden of smoking on cancer treatment, which is information that can benefit patients as well as health care providers.

“These data estimate that smoking could result in $3.4 billion in additional cancer treatment costs nationally if patients continue to smoke after being diagnosed with cancer,” says Warren, lead author on the study and professor and vice chairman for Research in Radiation Oncology at the Medical University of South Carolina (MUSC).

“We know that continued smoking can lead to bad treatment outcomes for patients with cancer. The 2014 Surgeon General’s Report concluded that continued smoking after a cancer diagnosis increases the risk of dying from cancer and other smoking related diseases. This is really the first time that the economic burden of smoking on cancer treatment has been estimated.”

The authors analyzed how smoking decreased the effectiveness of cancer treatment and estimated how much it would cost to treat recurrence caused by smoking.

Michael Cummings, Ph.D., co-author on the study, described the results as “really profound.” Cummings, a member of the Hollings Cancer Center’s Cancer Control Program and co-leader of tobacco control research at MUSC, says it’s been known for years that smoking in the general population increases health care costs because smoking causes so many diseases.

“With the rising costs of cancer treatment, we really wanted to understand the economic impact for cancer patients.”

The study shows that continued smoking increases the risk of cancer treatment failure and that the average additional cancer treatment costs can approach $11,000 for each patient. Warren says these estimates are very likely conservative. “The study only focused on the cost of additional cancer treatment, but did not include the cost of treating side effects from smoking, such as increased cancer treatment toxicity or treatment of other smoking related diseases such as heart disease, strokes and other diseases known to be caused by continued smoking.”

Kathleen Cartmell, Ph.D., a study co-author and associate professor in the College of Nursing at MUSC, says the study establishes important groundwork to know the financial magnitude of how smoking can affect cancer treatment. “Now, we are better prepared to approach patients, providers and health systems to develop approaches to help prevent these costs.”

That’s no small feat, especially as the future of health care shifts more to value-based medicine that provides the best care at the lowest cost. A commentary on Warren’s study in JAMA Network Open published today states, “the study provides a tool for representing the economic consequences of a known clinical phenomenon to show that continued smoking during cancer treatment not only harms patient health but also creates a financial burden for patients, clinicians and the health care system overall.”

Warren says the study did not report on how smoking cessation would affect cost, but smoking cessation, even after a cancer diagnosis, is currently the best method health providers have to try and prevent the harmful effects of smoking on cancer treatment.

“The best decision a patient with cancer can make is to decide to quit smoking. The next step is to put resources into identifying the best treatment approach for all cancer patients, including those who smoke when they are diagnosed with cancer.”

The National Cancer Institute (NCI) also has recognized the importance of smoking cessation by developing smoking cessation programs at 42 NCI-Designated Cancer Centers nationwide.

Hollings Cancer Center Director Gustavo Leone, Ph.D., says the center’s Cancer Control Program has some of the leading experts pioneering advances in the area. Hollings is an NCI-Designated Cancer Center and the only one in the state.

“Our patients need our help,” Leone says. “We have a dedicated smoking cessation program at MUSC to help patients quit. We have many investigators at Hollings with expertise in smoking cessation as well as investigating the impacts of smoking on health and the effectiveness of cancer treatment. We want to provide ways our patients can have the best outcomes.”

###

Media Contact
Dawn Brazell
[email protected]

Original Source

https://web.musc.edu/about/news-center/2019/04/05/costs-associated-with-smoking-by-patients-with-cancer

Related Journal Article

http://dx.doi.org/10.1001/jamanetworkopen.2019.1703

Tags: AddictioncancerHealth CareHealth Care Systems/ServicesMedicine/HealthSmoking/Tobacco
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Unraveling EMT’s Role in Colorectal Cancer Spread

August 2, 2025
Gut γδ T17 Cells Drive Brain Inflammation via STING

Gut γδ T17 Cells Drive Brain Inflammation via STING

August 2, 2025

Agent-Based Framework for Assessing Environmental Exposures

August 2, 2025

MARCO Drives Myeloid Suppressor Cell Differentiation, Immunity

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    38 shares
    Share 15 Tweet 10
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unraveling EMT’s Role in Colorectal Cancer Spread

Gut γδ T17 Cells Drive Brain Inflammation via STING

Agent-Based Framework for Assessing Environmental Exposures

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.